Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
4 Medical Product Stocks to Watch From a Challenging Industry (Revised)
06:41am, Tuesday, 03'rd Feb 2026
The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.
Keybank National Association OH Raises Stock Holdings in Boston Scientific Corporation $BSX
04:40am, Tuesday, 03'rd Feb 2026
Keybank National Association OH raised its stake in Boston Scientific Corporation (NYSE: BSX) by 43.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exc
BALA CYNWYD, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j
4 Medical Product Stocks to Watch From a Challenging Industry
10:11am, Monday, 02'nd Feb 2026
The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.
Mediolanum International Funds Ltd Has $32.70 Million Stock Position in Boston Scientific Corporation $BSX
04:28am, Sunday, 01'st Feb 2026
Mediolanum International Funds Ltd reduced its stake in shares of Boston Scientific Corporation (NYSE: BSX) by 35.9% in the undefined quarter, according to the company in its most recent 13F filing wi
Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Friday, 30'th Jan 2026
Beyond analysts' top-and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the
Artisan Global Opportunities Fund Q4 2025 Portfolio Update
09:39am, Thursday, 29'th Jan 2026
Among our top contributors in Q4 were Argenx, Lam Research and Insmed. Among our biggest detractors in Q4 were Oracle, Netflix and BAE Systems. During the quarter, we initiated new positions in RTX (R
Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?
08:30am, Wednesday, 28'th Jan 2026
BSX heads into Q4 earnings with strong MedSurg momentum and Cardiovascular growth, as revenue and EPS estimates point to double-digit gains.
Exane Asset Management Acquires Shares of 79,463 Boston Scientific Corporation $BSX
05:58am, Wednesday, 28'th Jan 2026
Exane Asset Management acquired a new position in shares of Boston Scientific Corporation (NYSE: BSX) in the third quarter, according to the company in its most recent 13F filing with the SEC. The ins
Bank of New York Mellon Corp Has $1.08 Billion Stake in Boston Scientific Corporation $BSX
05:18am, Wednesday, 28'th Jan 2026
Bank of New York Mellon Corp reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 1.6% in the third quarter, according to the company in its most recent 13F filing with the S
Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage
02:54pm, Monday, 26'th Jan 2026
The Investment Committee debate the latest Calls of the Day.
PAHC vs. BSX: Which Stock Is the Better Value Option?
12:40pm, Monday, 26'th Jan 2026
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investo
Cullen Frost Bankers Inc. Sells 5,633 Shares of Boston Scientific Corporation $BSX
04:58am, Sunday, 25'th Jan 2026
Cullen Frost Bankers Inc. lowered its stake in shares of Boston Scientific Corporation (NYSE: BSX) by 1.6% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 35
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider
07:00pm, Friday, 23'rd Jan 2026
In the closing of the recent trading day, Boston Scientific (BSX) stood at $92.51, denoting a +1.34% move from the preceding trading day.
Boston Scientific Corporation $BSX Stock Position Raised by Arkadios Wealth Advisors
03:52am, Thursday, 22'nd Jan 2026
Arkadios Wealth Advisors grew its position in shares of Boston Scientific Corporation (NYSE: BSX) by 81.9% in the undefined quarter, according to the company in its most recent filing with the Securit
